Wolverine Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,700
Closed -$5.79M 1624
2024
Q4
$5.79M Sell
15,700
-12,400
-44% -$5.19M 0.06% 285
2024
Q3
$14.6M Sell
28,100
-10,000
-26% -$5.34M 0.16% 147
2024
Q2
$20.6M Buy
38,100
+22,500
+144% +$11.9M 0.23% 111
2024
Q1
$8.09M Buy
+15,600
New +$7.76M 0.09% 223
2018
Q1
Sell
-50,000
Closed -$11.3M 1486
2017
Q4
$11.3M Buy
+50,000
New +$10.6M 0.11% 160
2014
Q4
Sell
-250
Closed -$9K 2277
2014
Q3
$9K Sell
250
-14
-5% -$1.61K ﹤0.01% 2007
2014
Q2
$37K Buy
264
+249
+1,660% +$25.7K ﹤0.01% 1496
2014
Q1
$1K Buy
+15
New +$1.36K ﹤0.01% 2222
2013
Q4
Sell
-47
Closed -$1K 2746
2013
Q3
$1K Hold
47
﹤0.01% 2582
2013
Q2
$4K Buy
+47
New +$3.52K ﹤0.01% 2384

Other funds holding ELV

Wolverine Asset Management's ELV Position: Q1 2025 in Review

Wolverine Asset Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 13,282 shares — an estimated $4.9M sold.

Wolverine Asset Management first reported a position in ELV in Q2 2013 and held it in 15 quarters. The position peaked at $4.9M in Q4 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Wolverine Asset Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 13,282 Elevance Health shares in Q1 2025, an estimated $4.9M.
  • Wolverine Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 15 quarters.
  • Wolverine Asset Management's Elevance Health position peaked at $4.9M in Q4 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Wolverine Asset Management's 13F filing for Q1 2025, filed 12 May 2025.